Phosphatase inhibitors potentiate the release of vasoactive mediators from human endothelium.
Wheeler-Jones
C P
CP
Vascular Biology Research Centre, King's College London, U.K.
Houliston
R A
RA
Morgan
A J
AJ
Pearson
J D
JD
D002478:Cells, Cultured; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000187:drug effects / Q000378:metabolism*; D011464:Epoprostenol / Q000378:metabolism*; D004988:Ethers, Cyclic / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D006801:Humans; D007700:Kinetics; D019319:Okadaic Acid; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors*; D014471:Umbilical Veins; D014841:von Willebrand Factor / Q000096:biosynthesis* / Q000378:metabolism
D004988:Ethers, Cyclic; D014841:von Willebrand Factor; D019319:Okadaic Acid; D006632:Histamine; D011464:Epoprostenol; D017027:Protein Tyrosine Phosphatases